These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 30760699)
1. Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury. Zheng X; Zhang A; Binnie M; McGuire K; Webster SP; Hughes J; Howie SEM; Mole DJ Exp Mol Med; 2019 Feb; 51(2):1-14. PubMed ID: 30760699 [TBL] [Abstract][Full Text] [Related]
2. Kynurenine 3-monooxygenase limits de novo NAD Zhai Y; Chavez JA; D'Aquino KE; Meng R; Nawrocki AR; Pocai A; Wang L; Ma LJ Am J Physiol Cell Physiol; 2024 May; 326(5):C1423-C1436. PubMed ID: 38497113 [TBL] [Abstract][Full Text] [Related]
3. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation. Lassiter R; Merchen TD; Fang X; Wang Y Front Immunol; 2021; 12():671025. PubMed ID: 34305900 [TBL] [Abstract][Full Text] [Related]
4. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain. Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070 [TBL] [Abstract][Full Text] [Related]
5. Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice. Kubo H; Hoshi M; Mouri A; Tashita C; Yamamoto Y; Nabeshima T; Saito K Immunol Lett; 2017 Jan; 181():94-100. PubMed ID: 27889626 [TBL] [Abstract][Full Text] [Related]
6. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia. Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938 [TBL] [Abstract][Full Text] [Related]
7. Kynurenine-3-monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression. Chen Y; Zhang J; Yang Y; Xiang K; Li H; Sun D; Chen L J Cell Physiol; 2022 Dec; 237(12):4339-4355. PubMed ID: 36088660 [TBL] [Abstract][Full Text] [Related]
8. Kynurenine monooxygenase regulates inflammation during critical illness and recovery in experimental acute pancreatitis. Hayes AJ; Zheng X; O'Kelly J; Neyton LPA; Bochkina NA; Uings I; Liddle J; Baillie JK; Just G; Binnie M; Homer NZM; Murray TBJ; Baily J; McGuire K; Skouras C; Garden OJ; Webster SP; Iredale JP; Howie SEM; Mole DJ Cell Rep; 2023 Aug; 42(8):112763. PubMed ID: 37478012 [TBL] [Abstract][Full Text] [Related]
9. Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia. Tufvesson-Alm M; Schwieler L; Schwarcz R; Goiny M; Erhardt S; Engberg G Neuropharmacology; 2018 Aug; 138():130-139. PubMed ID: 29879409 [TBL] [Abstract][Full Text] [Related]
10. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions. Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848 [TBL] [Abstract][Full Text] [Related]
12. Bacterial expression of human kynurenine 3-monooxygenase: solubility, activity, purification. Wilson K; Mole DJ; Binnie M; Homer NZ; Zheng X; Yard BA; Iredale JP; Auer M; Webster SP Protein Expr Purif; 2014 Mar; 95(100):96-103. PubMed ID: 24316190 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback. Wilson K; Auer M; Binnie M; Zheng X; Pham NT; Iredale JP; Webster SP; Mole DJ Cell Death Dis; 2016 Apr; 7(4):e2197. PubMed ID: 27077813 [TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury. Mohib K; Wang S; Guan Q; Mellor AL; Sun H; Du C; Jevnikar AM Am J Physiol Renal Physiol; 2008 Jul; 295(1):F226-34. PubMed ID: 18480171 [TBL] [Abstract][Full Text] [Related]
15. Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO). Winkler D; Beconi M; Toledo-Sherman LM; Prime M; Ebneth A; Dominguez C; Muñoz-Sanjuan I J Biomol Screen; 2013 Sep; 18(8):879-89. PubMed ID: 23690293 [TBL] [Abstract][Full Text] [Related]
16. Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine. Kubota H; Kunisawa K; Niijima M; Hirakawa M; Mori Y; Hasegawa M; Fujigaki S; Fujigaki H; Yamamoto Y; Saito K; Nabeshima T; Mouri A Biochem Biophys Res Commun; 2022 Nov; 629():142-151. PubMed ID: 36116377 [TBL] [Abstract][Full Text] [Related]
17. A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics. Maddison DC; Alfonso-Núñez M; Swaih AM; Breda C; Campesan S; Allcock N; Straatman-Iwanowska A; Kyriacou CP; Giorgini F PLoS Genet; 2020 Nov; 16(11):e1009129. PubMed ID: 33170836 [TBL] [Abstract][Full Text] [Related]